2David L,Vesely D L.Atrial natriuretic hormones originating from the N-terminus of the atrial natriuretic factor prohaormane[J].Clin Expen Pharm Phy,1995,22:108-117.
3Tsunoda K,Abe K,Hagino T,et al.Hypertensive effect of losartan,a nonpeptide angiotensinⅡ receptor antagonist in essential hypertension[J].Am J Hypertens,1993,6:28-32.
4Vesely D L,Norris J S,Walters J M,et al.Atrial natriuretic prohormone peptides 1-30,31-67 and 79-98 vasodilate the aorta[J].Biochem Biophys Res Commun,1987,148:1540-1546.
5Vesely D L,Douglass M A,Dietg J R,et al.Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis,natriuresis,and/or kaliureses in humans[J].J Circulation,1994,90:1129-1134.
6European Society of Hypertension- European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens, 2003,21 (6) : 1011- 1153.
7Wang JG, Liu G, Wang X, et al. Long- term blood pressure control in older Chinese patients with isolated systolic hypertension:a progress report on the Syst-China trial. J Hum Hypertens, 1996,10(11) : 735-742.
8Nawrot TS,Staessen JA ,Thijs L, et al. Should pulse pressure become part of the Framingham risk score? J Hum Hypertens, 2004,18 (4) : 279-286.
9Staesscn JA, Thijs L, O'Brien ET, et al. Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension. Am J Hypertens, 2002,15 (10 Pt 1): 835- 843.
10Gueyffier F,Bulpitt C,Boissei JP,et al. Antihypertensive drugs in very old people: a subgroup Meta-analysis of randomised controlled trials. Lancet, 1999,353(9155) :793-796.
